WIKIMEDIA, JAGAFollowing an investigation by his former employer, MD Anderson Cancer Center, Molecular Pharmacology has retracted two papers coauthored by Bharat Aggarwal, citing “inappropriate” or “unacceptable” image manipulation, Retraction Watch reported yesterday (June 21).
The studies in question—a 2008 paper on how a semisynthetic flavone mediates antitumor responses, and a 2011 paper about a novel potential cancer drug—were cited 27 and five times, respectively, according to Thomson Reuters Web of Science.
“MD Anderson Cancer Center is committed to the highest standards of scientific integrity,” the institution noted in a statement sent to Retraction Watch. “Any scientific work that does not adhere to the highest standards of scientific integrity is not acceptable.”
The latest retractions follow on seven other retractions of papers coauthored by Aggarwal. All seven papers contained figures that were reused or manipulated, according to their associated retraction notices. Aggarwal has also amassed six corrections, two unexplained withdrawals, and two expressions of concern, according to Retraction Watch, a website the cancer researcher previously threatened to sue.